Alexion Pharmaceuticals Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Alexion Pharmaceuticals Inc
Access all reports
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the development and commercialization of innovative therapies for patients with rare and severe disorders. Alexion’s core business is focused on serving individuals afflicted with ultra-rare disorders through commercializing high-quality products that are priced based on their value. Alexion Pharmaceuticals is a subsidiary of AstraZeneca, and an American pharmaceutical company headquartered in Boston, Massachusetts
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
ALXN
Country
🇺🇸 United States